Cytokinetics Inc (NASDAQ:CYTK)

7.16
Delayed Data
As of Mar 27
 +0.04 / +0.56%
Today’s Change
3.05
Today|||52-Week Range
13.26
-10.61%
Year-to-Date

Today’s Trading

Previous close7.12
Today’s open7.11
Day’s range7.11 - 7.30
Volume270,220
Average volume (3 months)555,609
Market cap$276.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+66.94%
Earnings growth (this year)-142.07%
Earnings growth (next 5 years)--
Revenue growth (last year)+53.16%
P/E ratioNM
Price/Sales6.09
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...-0.21-1.09%
RIGLRigel Pharmaceutical...+0.06+1.83%
NATRNatures Sunshine Pro...+0.14+1.08%
CTSOCytosorbents Corp+0.26+1.85%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$46.9M
Annual profit (last year)-$14.6M
Net profit margin-31.20%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account